Covered recipient · General Payments record
MARGARET PARSONS
Allopathic & Osteopathic Physicians Dermatology Procedural Dermatology
General Payments · PY2018–2024
$2,190.02
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $386.64 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $231.83 | 28 |
| Galderma Laboratories, L.P. | $37.24 | 2 |
| MEDLINE INDUSTRIES LP | $28.20 | 1 |
| E.R. Squibb & Sons, L.L.C. | $25.06 | 1 |
| UCB, Inc. | $20.99 | 1 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $15.61 | 1 |
| Amgen Inc. | $14.35 | 1 |
| GENZYME CORPORATION | $13.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.10 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187702 | CMS |
| ABBVIE INC. | $8.27 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187704 | CMS |
| ABBVIE INC. | $4.17 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187706 | CMS |
| ABBVIE INC. | $6.03 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187708 | CMS |
| ABBVIE INC. | $5.46 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187710 | CMS |
| ABBVIE INC. | $11.58 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187712 | CMS |
| ABBVIE INC. | $8.50 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187714 | CMS |
| ABBVIE INC. | $4.33 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187716 | CMS |
| ABBVIE INC. | $6.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187718 | CMS |
| ABBVIE INC. | $9.75 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187720 | CMS |
| ABBVIE INC. | $5.45 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187722 | CMS |
| ABBVIE INC. | $21.58 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187724 | CMS |
| ABBVIE INC. | $8.97 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187726 | CMS |
| ABBVIE INC. | $5.43 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187728 | CMS |
| ABBVIE INC. | $5.87 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187730 | CMS |
| ABBVIE INC. | $5.89 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187732 | CMS |
| ABBVIE INC. | $9.62 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187734 | CMS |
| ABBVIE INC. | $6.71 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187736 | CMS |
| ABBVIE INC. | $23.38 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187738 | CMS |
| ABBVIE INC. | $5.19 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187740 | CMS |
| ABBVIE INC. | $10.43 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187742 | CMS |
| ABBVIE INC. | $6.48 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187744 | CMS |
| ABBVIE INC. | $5.05 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187746 | CMS |
| ABBVIE INC. | $4.58 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187748 | CMS |
| ABBVIE INC. | $10.49 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187750 | CMS |
| ABBVIE INC. | $6.51 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187752 | CMS |
| ABBVIE INC. | $5.15 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187754 | CMS |
| ABBVIE INC. | $12.71 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105187756 | CMS |
| Amgen Inc. | $14.35 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117347712 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.06 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101574507 | CMS |
| Galderma Laboratories, L.P. | $21.40 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145320425 | CMS |
| Galderma Laboratories, L.P. | $15.84 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145320427 | CMS |
| GENZYME CORPORATION | $13.36 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139701579 | CMS |
| Medline Industries LP | $28.20 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144137592 | CMS |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $15.61 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153813536 | CMS |
| UCB, Inc. | $20.99 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143040993 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.